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Abstract After short duplexes of synthetic 21^23 nt RNAs
(siRNA) were reported to be e¡ective in silencing speci¢c genes,
a vector-based approach for siRNAs was demonstrated in mam-
malian cultured cell lines. However, the e¡ect of RNA inter-
ference (RNAi) on various di¡erentiated cells in live animals
remains unknown. In this report, we demonstrate that trans-
genically supplied siRNA can silence ubiquitously expressed en-
hanced green £uorescent protein in every part of the mouse and
rat body. These results suggest that transgenic RNAi could
function as an alternative method of gene silencing by applying
homologous recombination to embryonic stem (ES) cells, and
should be successful even in species where ES cell lines remain
unestablished.
- 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Double-stranded RNA (dsRNA)-based gene silencing or
RNA interference (RNAi) is an ancient and evolutionarily
conserved mechanism for sequence-speci¢c post-transcription-
al gene silencing among species from various kingdoms (re-
viewed in [1,2]). The system probably is the most well-studied
in Caenorhabditis elegans where long dsRNAs, ingested as
part of the food source, are processed into short (19^25 nu-
cleotides) small interfering RNAs (siRNA) by a ribonucleo-
tide^protein complex. The shorter siRNAs then prompt the
speci¢c degradation of homologous cellular RNA. Until re-
cently, the use of RNAi to silence mammalian genes was not
applicable because the introduction of dsRNAs longer than 30
nt elicits a viral response that is sequence-non-speci¢c [3].
However, the introduction of short duplexes of synthetic
21^23 nt RNAs (siRNA) into mammalian cells have a gene-
speci¢c silencing function [4]. The limitation of this method is
that the transfected synthetic siRNA works for only a few
days in mammalian cells. To circumvent this problem, a vec-
tor-based approach for the synthesis of siRNAs which were
driven by RNA polymerase III (pol III) promoter was dem-
onstrated to silence various genes in mammalian cultured cell
lines [5^11]. Recently, RNAi from an exogenously adminis-
tered plasmid was shown to silence a concomitantly adminis-
tered transgene expression in adult mouse livers [12]. How-
ever, the e¡ect was observed only in a transient expression
system and the e¡ect was shown only in the liver. In this
report, we establish a transgene-based RNAi system using a
transgene containing an enhanced green £uorescent protein
(EGFP) siRNA driven by a pol III promoter, suggesting
that it may be an alternative method for gene disruption.
This system was also successful in silencing EGFP expressed
in the rat, indicating that transgenic RNAi could analyze the
function of genes in animals where homologous recombina-
tion is not possible due to the lack of embryonic stem (ES) cell
lines.
2. Materials and methods
2.1. Plasmid construction
The H1 promoter [13] was PCR ampli¢ed from genomic DNA of
the human 293 cell line, using the following primers: 5P-CCGCT-
CGAGAAGCTTCTAGACTGCAGTGGTCTCATACAGAACTTA-
TAAGATTCCC-3P and 5P-GATATCGGATCCGCGGAATTCGA-
ACGCTGACGTCATCAACCC-3P. The PCR product was digested
with EcoRV and XhoI, and cloned into the XhoI and blunted SacI
site of pBluescript II SKþ (pH1). To insert the target sequence that
encodes the EGFP siRNA, DNA oligos (5P-CCCAACCACTACCT-
GAGCACCCAGTTCAAGAGACTGGGTGCTCAGGTAGTGGT-
TTTTTTGGAAA-3P and 5P-CTAGTTTCCAAAAAAACCACTAC-
CTGAGCACCCAGTCTCTTGAACTGGGTGCTCAGGTAGTG-
GTTGGGTGCA-3P) were synthesized, annealed and cloned into the
PstI and XbaI site of pH1 (pH1/siRNAEGFP).
CAG/HcRed1 was constructed from the pCX-EGFP [14] and
pHcRed1-N1 (Clontech) plasmids. NotI and XhoI sites were intro-
duced between the CAG promoter and the rabbit L-globin polyA
region of pCX-EGFP (pCXNX). The HcRed1 gene was ampli¢ed
by PCR using primers including NotI or XhoI sites at their 5P ends.
Both the PCR product and pCXNX were digested with NotI and
XhoI, and were ligated (pRed). To produce the siRNA transgenic
animals with red £uorescence as an RNAi transgene marker, pH1/
siRNAEGFP was digested with BamHI and HindIII, and inserted into
the corresponding restriction sites of pRed (pGtoR).
2.2. Animals and DNA injection
The ‘green’ mouse line, C57BL/6 TgN(act-EGFP)OsbC14-Y01-
FM131, and the ‘green’ rat line, Rat SD TgN(act-EGFP)Osb4, have
been established as described previously [14,15]. Fertilized green
mouse eggs were prepared by fertilizing wild-type (B6D2F1) eggs in
vitro with sperm from homozygous ‘green mice’. Fertilized green rat
eggs were obtained by mating wild-type (SD) females with heterozy-
gous ‘green rat’ males. The pGtoR and pRed plasmids, which were
digested with SalI and BamHI and puri¢ed from an agarose gel, were
injected into the pronuclear stage of fertilized eggs. The injected em-
bryos were cultured in kSOM until the blastocyst stage or immedi-
ately implanted into pseudopregnant animals to generate transgenic
animals.
2.3. Microscopic analysis
DNA-injected embryos and newborn animals were observed on a
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£uorescence inverted microscope IX70 (Olympus) and £uorescence
stereoscopic microscope SZX12 (Olympus). The green and red £uo-
rescences were photographed under 510 nm (green, EGFP) and 610
nm (red, HcRed1) band pass ¢lters equipped with a CoolSNAP fx
and cx color digital camera (Roper).
2.4. Genotype analysis
Genotypes of all mice and fetuses were determined by PCR analysis
on tail or fetal DNA. PCR was carried out using the EGFP (GAAT-
TCGCCACCATGGTGAGC, GAATTCTTACTTGTACAGCTCG-
TCC) and human H1 promoter primers (GAACGCTGACGTCAT-
CAACCC, TGGTCTCATACAGAACTTATAATAAGATTCCC).
2.5. Immunoblot analysis
Total cellular proteins were extracted with 30 mM 3-[(3-cholamido-
propyl) -dimethylammonio] -1 -propane- sulfonate/phosphate-bu¡ered
saline with 1 mM phenylmethylsulfonyl £uoride, separated by SDS^
PAGE on 12.5% polyacrylamide gels, and transferred onto polyviny-
lidene di£uoride membranes. EGFP, CD9, and Shc were visualized
using an ECL detection system (Amersham Bioscience) after incuba-
tion with rat anti-EGFP monoclonal antibody (kindly provided by
Dr. Fujita of Mitsubishi-Kasei Institute of Life Sciences), anti-CD9
antibody KMC8.8 (Pharmingen) or anti-Shc antibody c-20 (Santa
Cruz Biotechnology). Either a horseradish peroxidase-linked goat
anti-rat or rabbit IgG (Chemicon) was used for the secondary anti-
body. The visualized signals were quanti¢ed by the NIH image pro-
gram.
3. Results and discussion
Although long dsRNAs are thought to be detrimental to
mammalian cells [3], this may not be applicable in early em-
bryos. In this regard, when mouse eggs are injected with
dsRNA corresponding to GFP, RNA-induced gene silencing
was reported [16,17]. However, the silencing e¡ect continued
for only a few days. The injection of synthesized siRNA (21-
mer) of EGFP into ‘green’ one cell eggs is also e¡ective in
silencing the expression of the transgene, but again only for a
limited time period (data not shown). Fluorescence began to
re-appear after the blastocyst stage. This was probably due to
a dilution of injected siRNA by a rapid increase of embryonic
body mass. To circumvent this limitation, we investigated the
possibility of a transgene-based gene silencing system to main-
tain the RNAi e¡ect in animals for an extended period.
‘Green’ mice [14] and rats [15], i.e. mice and rats that express
EGFP in all tissues and cells, were used as a model system.
The silencing EGFP transgenic construct consisted of the pol
III human H1 promoter [13] with a hairpin precursor se-
quence for siRNA (Fig. 1a). The transgene also contained
HcRed1 driven by a CAG promoter, which was designed to
monitor the genomic integration of the transgene by turning
the cells ‘red’ while the dsRNA silences the ‘green’. This
‘green to red’ transgenic construct (pGtoR) was injected
into the pronuclei of ‘green’ mouse eggs prepared by fertiliz-
ing wild-type B6D2F1 eggs in vitro with sperm from homo-
zygous ‘green’ mice. Initially, silencing of EGFP was exam-
ined in mouse preimplantation blastocysts. The embryos were
cultured for 3 days in vitro in kSOM medium [18] following
transgene injection. The blastocysts appeared ‘red’ due to the
expression of the HcRed1 portion of the transgenic construct,
indicating injection was successful. Signi¢cantly, EGFP £uo-
rescence was greatly reduced. This EGFP silencing was not
due to the expression of HcRed1 because when only the pRed
(CAG/HcRed1) construct was injected, the intensity of EGFP
£uorescence in the blastocysts was not reduced (Fig. 1b).
Following injection of the transgenes, the mouse eggs were
Fig. 1. Transgenic-based gene silencing in mouse embryos. a: A
pGtoR (pH1/siRNAEGFP-CAG/HcRed1) transgene was constructed.
Two oligonucleotides containing sense and antisense 21 nt sequences
from the EGFP coding region (blue colored sequence), a 9 nt spacer
sequence which provided a loop structure, and a transcription termi-
nation signal of ¢ve thymidines (red colored sequence) were an-
nealed and inserted downstream of the H1 promoter (pH1/
siRNAEGFP). b: Green eggs, obtained from wild-type females mated
with homozygous ‘green’ males, were injected with pGtoR, cultured
in kSOM for 3 days, and observed for HcRed (middle column) and
EGFP (right column) expression by £uorescence microscopy.
‘Green’ blastocysts with no additional transgene (top row), ‘green’
blastocysts with the pRed transgene (middle row) and ‘silenced’
blastocysts with the pGtoR transgene (bottom row). c: Day 10.5
embryos were recovered and their £uorescence observed (from the
left, ‘green’ embryo with pRed GMR #1, with pGtoR GMGR #1, 2
and 3, respectively). d: Immunoblot analysis of EGFP in day 10.5
embryos. The lysates from E10.5 embryo of one pRed integrated
transgenic (GMR #1) and three pGtoR integrated embryos (GMGR
#1, 2 and 3 as shown above) were analyzed by immunoblotting
with anti-EGFP (top) and anti-CD9 (bottom) antibody. e: The in-
tensity of the bands in panel d was quanti¢ed and normalized to
the control EGFP amount.
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transplanted to the oviducts of pseudopregnant females.
Transgenic founder embryos were recovered at day 10.5 and
examined for EGFP silencing. In these embryos, the green
£uorescence was diminished in all organs including the heart
which showed the strongest expression of EGFP at this stage
of development (Fig. 1c). In contrast, when synthesized si-
RNA was injected into one cell stage embryos, the EGFP
silencing e¡ect disappeared by day 10.5 and all the embryos
showed comparable green £uorescence to normal green em-
bryos (data not shown), indicating that the transgenic ap-
proach extended the silencing e¡ect. Proteins from one
pRed transgenic embryo GMR #1 (as a control) and three
pGtoR transgenic embryos GMGR #1 to 3 that showed
‘red’ £uorescence and were positive for human H1 promoter
sequence in genomic PCR screening were prepared by homog-
enizing whole embryos and the amount of EGFP was ana-
lyzed by immunoblotting (Fig. 1d). Following quanti¢cation,
EGFP expression of the three founder mice was reduced to
18, 4 and 24% of the control level, respectively (Fig. 1e). In
contrast, the amount of CD9 was not a¡ected by the integra-
tion of the transgene (Fig. 1d).
Newborn founder mice which had incorporated the trans-
genic construct were identi¢ed by their ‘red’ £uorescent ap-
pearance and genomic PCR analysis. ‘Red mice’ that con-
tained the pRed transgene alone showed no decrease in
EGFP £uorescence when compared to the original ‘green’
mice. However, mice containing the pGtoR transgene (e.g.
GMGR #4) showed a signi¢cant decrease in their ‘green’ £uo-
rescence (Fig. 2a). To observe the silencing of EGFP in var-
ious tissues, brain, heart, liver, pancreas, kidney and skin were
collected from the newborn mice with a genetic background of
‘green’ (GM #2), ‘green with pRed’ (GMR #3) and ‘green
with pGtoR’ (GMGR #5). The silencing e¡ect was nearly
complete in both the heart and pancreas, two organs that
express EGFP intensively (Fig. 2b). Furthermore, all the tis-
Fig. 2. Transgenic-based gene silencing in newborn mice. Mice were
obtained by injecting ‘green eggs’ with pRed or pGtoR that con-
tains the siRNAEGFP sequence. a: A newborn ‘green’ mouse without
an additional transgene (GM #1), a ‘green’ mouse containing the
pRed transgene (GMR #2), and a ‘silenced green’ mouse with the
pGtoR transgene (GMGR #4). b: Various organs were removed
from newborn founder mice (GM #2, GMR #3, GMGR #5) con-
taining the genetic backgrounds indicated above and photographed
under normal lighting (left), 510 nm (right) and 610 nm (center)
band pass ¢lter. The exposure time for each panel was adjusted to
obtain optimal images. The absolute £uorescence in muscle and
pancreas is brighter than in other tissues. Fig. 3. Transgenic-based EGFP silencing in adult mice and the F1
generation. a: Fluorescent view of abdominal muscle obtained from
8 week old ‘green’ mouse (GM #3) and from ‘green with pGtoR’
transgenic mouse (GMGR #4 in Fig. 2a). b: Immunoblot of proteins
extracted from abdominal muscle and skin. Eight week old double
transgenic mice with a ‘green’ genetic background and with or with-
out pGtoR integration were compared for EGFP silencing. A
B6D2F1 mouse was used to analyze a wild-type mouse. c: Fluores-
cent view of day 12.5 embryos obtained from B6D2F1 females
mated with the GMGR #4 transgenic male from b. Genetic back-
grounds of embryos #1 to #4 are as indicated in the table shown in
d. d: The embryos shown in c were homogenized and analyzed by
immunoblotting. The + and 3 in the table indicate the result of
genotyping the EGFP and H1 promoter sequences by PCR.
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sues examined, i.e. brain, liver, kidney, skin, showed a de-
crease in £uorescence in the siRNA transgenic animals, sug-
gesting that the silencing e¡ect was widespread throughout the
body. Taken together, these results indicate the transgenic
RNAi system enables us to decrease endogenous gene expres-
sion in all the organs and at any developmental stage.
It was important to investigate whether the transgenic
RNAi silencing e¡ect was transmitted to the next generation.
EGFP expression in abdominal muscle and skin in the 8 week
old GMGR #4 transgenic mouse was silenced based on both
£uorescence and immunoblotting analysis (Fig. 3a,b). Day
12.5 F1 embryos from this transgenic mouse were also exam-
ined. Because the inheritance of the original EGFP transgene
and the pGtoR transgene containing the RNAi sequence oc-
curs independently, embryos with various genetic back-
grounds were produced. However, when the pGtoR construct
was transmitted, the expression of EGFP was diminished (Fig.
3c,d).
We examined the silencing e¡ect of pGtoR in a ‘green’
transgenic rat line [15]. Fertilized eggs, recovered from wild-
type SD female rats which had been mated with ‘green’ trans-
genic male rats, were injected with pGtoR as described for the
mouse, and the resultant transgenic rats were examined for
green £uorescence. The original transgenic rat embryo was
ubiquitously green (R #2) (Fig. 4a). However, after incorpo-
ration of the second transgene, pGtoR, the £uorescence be-
came almost non-detectable (R #5 and 6). The silencing was
speci¢c for EGFP because the Shc protein showed no decrease
in its expression (Fig. 4b). While the silencing e¡ect appeared
more e¡ective in rats compared to mice, this might be due to
the two to three times higher expression of EGFP in the trans-
genic ‘green’ mice compared to the ‘green’ rats as measured by
£ow cytometry (data not shown).
The success of transgenic silencing will bring several impor-
tant advances in the ¢eld of gene function analysis in mam-
mals. First, since the silencing e¡ect is inheritable, the system
can provide a new type of gene ‘knockout’ or ‘knockdown’
method. While homologous recombination using ES cell lines
is a well-established method to study the function of a partic-
ular gene, the method is time- and labor-intensive. In contrast,
the RNAi approach is relatively rapid. Since a RNAi corre-
sponding to a particular gene functions in ‘trans’, the pheno-
typic e¡ect of gene silencing experiments can be examined in
hemizygous mice. Second, the results in this paper demon-
strate that silencing could be e¡ective in any type of organ
and any kind of cell from the early embryo until the adult.
Third, silencing in rats indicates that silencing could become a
powerful tool to produce genetically modi¢ed animals in those
species where ES cell lines are not established and homolo-
gous recombination has not been demonstrated. Finally, in
the future it should be possible to express a particular
RNAi in selected organs or at a speci¢c developmental time
by using methods such as the Cre/loxP recombination system
and/or the tetracycline switch promoter [19,20].
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Fig. 4. Transgenic-based EGFP silencing in the rat. a: Fluorescent
images of day 11.5 rat embryos containing the pGtoR transgene but
without the EGFP transgene (R #1), with the EGFP transgene but
without pGtoR (R #2), with neither the EGFP or pGtoR trans-
genes (R #3 and R #4), and with both the EGFP and pGtoR
transgenes (R #5 and R #6). b: Protein extracts from E11.5 rat em-
bryos from R #1 to R #6 were analyzed by immunoblotting with
anti-EGFP (top) and anti-Shc (bottom) antibody. Their respective
genetic background is indicated.
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